Heres what todays earnings report tells us about how were progressing on our ambitions to build the future of healthcare: Personalization as the core of our platform means we can provide access to solutions to address the concerns of an even more diverse set of customers who trust us with their care, from the 65-year-old man looking to address his sexual and cardiovascular health, to the 45-year-old woman going through perimenopause looking to combat hair loss, to the 25-year-old man dealing with sexual health and hair loss for the first time
Microdosing is a much more economical option as well, with the long-term benefits being hard to quantify as they encompass mental and physical benefits
The combination of GLP-1 therapy and resistance training produces results that neither achieves alone
Your gel packs melted early If your gel packs melt before you reach your destination, assess the situation before panicking
TRIUMPH-4 didn't specifically study patients with established cardiovascular disease, but TRIUMPH-3 is evaluating retatrutide in this population with results expected in 2026
These findings underscore the broader role of metabolite-driven protein modifications in immune and metabolic homeostasis